Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

View source ↗

Summary

The trial evaluating a bismuth-containing quadruple therapy for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-containing quadruple therapy

Snippet

Sponsor: Yueyue Li | Conditions: Helicobacter Pylori Infection | Status: COMPLETED